Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Blockade of USP14 potentiates type I interferon signaling and radiation-induced antitumor immunity via preventing IRF3 deubiquitination

Published:2022-10-07 Issue:6 Volume:45 Page:1347-1361
ISSN:2211-3428
Container-title:Cellular Oncology
language:en
Short-container-title:Cell Oncol.

Author:

Wu Weijian,Xu Huiying,Liao Chenyang,Wang Youqiao,Wu Ruirui,Wu Jiaxin,Zheng Wenlv,Li Yunzhi,Jin Chaoying,Zhao Yuxuan,Quan Junmin,Yue Xin,Bu Xianzhang

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,Molecular Medicine,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s13402-022-00724-2.pdf

Reference41 articles.

1. D.E. Citrin, Recent developments in radiotherapy. N. Engl. J. Med. 377, 1065–1075 (2017). https://doi.org/10.1056/NEJMra1608986

2. E.B. Golden, D. Frances, I. Pellicciotta, S. Demaria, M. Helen Barcellos-Hoff, S.C. Formenti, Radiation fosters dose-dependent and chemotherapy-induced immunogenic cell death. OncoImmunology 3, e28518 (2014). https://doi.org/10.4161/onci.28518

3. C. Grassberger, S.G. Ellsworth, M.Q. Wilks, F.K. Keane, J.S. Loeffler, Assessing the interactions between radiotherapy and antitumour immunity. Nat. Rev. Clin. Oncol. 16, 729–745 (2019). https://doi.org/10.1038/s41571-019-0238-9

4. C. Twyman-Saint Victor, A.J. Rech, A. Maity, R. Rengan, K.E. Pauken, E. Stelekati, J.L. Benci, B. Xu, H. Dada, P.M. Odorizzi, R.S. Herati, K.D. Mansfield, D. Patsch, R.K. Amaravadi, L.M. Schuchter, H. Ishwaran, R. Mick, D.A. Pryma, X. Xu, et al., Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer. Nature 520, 373–377 (2015). https://doi.org/10.1038/nature14292

5. L. Apetoh, F. Ghiringhelli, A. Tesniere, M. Obeid, C. Ortiz, A. Criollo, G. Mignot, M.C. Maiuri, E. Ullrich, P. Saulnier, H. Yang, S. Amigorena, B. Ryffel, F.J. Barrat, P. Saftig, F. Levi, R. Lidereau, C. Nogues, J.-P. Mira, et al., Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 13, 1050–1059 (2007). https://doi.org/10.1038/nm1622

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASSESSMENT OF DYNAMIC CHANGES IN THE LOCAL STATUS OF PATIENTS WITH OROPHARYNGEAL CANCER ON THE BACKGROUND OF RADIATION AND CHEMORADIOTHERAPY;Art of Medicine;2024-06-29

2. USP14 negatively regulates IFN signaling by dampening K63-linked ubiquitination of TBK1 in black carp;Fish & Shellfish Immunology;2024-06

3. Usp14 Negatively Regulates Ifn Signaling by Dampening K63-Linked Ubiquitination of Tbk1 in Black Carp;2024

4. The Emerging Role of Deubiquitinases in Radiosensitivity;International Journal of Radiation Oncology*Biology*Physics;2023-12

5. USP14 predicts poorer survival outcomes and promotes tumor progression in endometrial carcinoma by activating NF-κB signaling;Aging;2023-11-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3